Skip to main content

Advertisement

Table 1 PABAK values for each ARV – 2-level interpretation

From: Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-naive HIV-infected patients in Asia: TASER-M cohort analysis

Drug class Drug Proportion observed agreement PABAK 95%CI of PABAK
NNRTI Efavirenz 0.94 0.88 (0.86 - 0.91)
  Etravirine 0.99 0.97 (0.96 - 0.99)
  Nevirapine 0.99 0.98 (0.97 - 0.99)
NRTI Abacavir 0.99 0.97 (0.96 - 0.99)
  Didanosine 0.99 0.97 (0.96 - 0.99)
  Emtricitabine 1.00 1.00 (1.00 -1.00)
  Lamivudine 1.00 1.00 (1.00 -1.00)
  Stavudine 0.99 0.98 (0.97 - 0.99)
  Tenofovir 1.00 0.99 (0.99 - 1.00)
  Zidovudine 0.98 0.97 (0.95 - 0.98)
PI Atazanavir/r 1.00 0.99 (0.99 - 1.00)
  Darunavir/r 1.00 1.00 (1.00 - 1.00)
  Lopinavir/r 1.00 1.00 (0.99 - 1.00)
  Saquinavir/r 1.00 1.00 (0.99 - 1.00)
  Tipranavir/r 1.00 1.00 (0.99 - 1.00)